Prosecution Insights
Prosecution Insights
1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Bluestone Pharma GmbH has 1 pending office action currently active. This action is managed by 1 distinct examiner, ARMSTRONG, SUSANNAH SIPPLE, who is listed as the busiest examiner with the pending action. There are 0 distinct art units reported for this portfolio.
The presence of a pending office action and a distinct examiner indicates that the company's current patent activity is limited to a single point of contact at the patent office. This concentration means the entirety of the company's active prosecution rests with this individual. Without additional art units or examiners, the company's current strategy is dependent on the 0 art units and the single examiner's review.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ARMSTRONG, SUSANNAH SIPPLE | 1 | 30.0% | +53.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18856473 | COMPRESSED PRODUCT COMPRISING PROBIOTICS AND METHOD FOR ITS PRODUCTION | ARMSTRONG, SUSANNAH SIPPLE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18856473 | COMPRESSED PRODUCT COMPRISING PROBIOTICS AND METHOD FOR ITS PRODUCTION | ARMSTRONG, SUSANNAH SIPPLE | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18856473 | COMPRESSED PRODUCT COMPRISING PROBIOTICS AND METHOD FOR ITS PRODUCTION | ARMSTRONG, SUSANNAH SIPPLE | — | §103§112 | Non-Final OA | — | Pending | Oct 11, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBluestone Pharma GmbH has 1 pending office actions as of October 2026, spread across 0 art units and 1 examiners.
Susannah Sipple Armstrong has the most, with 1 of Bluestone Pharma GmbH's pending office actions.